Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021;13:1–8.

Article  Google Scholar 

Ojo O, Wang X-H, Ojo OO, Orjih E, Pavithran N, Adegboye ARA, Feng Q-Q, McCrone P. The effects of COVID-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:1095.

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Mahoney LL, Highton PJ, Kudlek L, Morgan J, Lynch R, Schofield E, Sreejith N, Kapur A, Otunla A, Kerneis S. The impact of the COVID-19 pandemic on glycaemic control in people with diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2022;24:1850–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silverii GA, Delli Poggi C, Dicembrini I, Monami M, Mannucci E. Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies. Acta Diabetol. 2021;58:1603–11.

Article  PubMed  PubMed Central  Google Scholar 

Sardu C, D’Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, Maggi P, Coppola N, Paolisso G, Marfella R. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes Care. 2020;43:1408–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sardu C, Gargiulo G, Esposito G, Paolisso G, Marfella R. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19. Cardiovasc Diabetol. 2020;19:1–4.

Article  Google Scholar 

Matarese A, Gambardella J, Sardu C, Santulli G. miR-98 regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19. Biomedicines. 2020;8:462.

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’onofrio N, Scisciola L, Sardu C, Trotta MC, De Feo M, Maiello C, Mascolo P, De Micco F, Turriziani F, Municinò E. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte. Cardiovasc Diabetol. 2021;20:99.

Article  PubMed  PubMed Central  Google Scholar 

Ahrens KF, Neumann RJ, Kollmann B, Plichta MM, Lieb K, Tüscher O, Reif A. Differential impact of COVID-related lockdown on mental health in Germany. World Psychiatry. 2021;20:140.

Article  PubMed  PubMed Central  Google Scholar 

Schäfer I, Hansen H, Menzel A, Eisele M, Tajdar D, Lühmann D, Scherer M. The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study. BMC Fam Pract. 2021;22:125.

Article  PubMed  PubMed Central  Google Scholar 

Aragona M, Rodia C, Bertolotto A, Campi F, Coppelli A, Giannarelli R, Bianchi C, Dardano A, Del Prato S. Type 1 diabetes and COVID-19: the “lockdown effect.” Diabetes Res Clin Pract. 2020;170: 108468.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barmpagianni A, Lambadiari V, Papazafiropoulou A, Kountouri A, Stergiou A, Melidonis A, Liatis S. Glycemic control of patients with type 1 diabetes using an insulin pump before and during the COVID-19–associated quarantine. Diabetes Technol Ther. 2021;23:320–1.

Article  CAS  PubMed  Google Scholar 

Capaldo B, Annuzzi G, Creanza A, Giglio C, De Angelis R, Lupoli R, Masulli M, Riccardi G, Rivellese AA, Bozzetto L. Blood glucose control during lockdown for COVID-19: CGM metrics in Italian adults with type 1 diabetes. Diabetes Care. 2020;43: e88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Dalmazi G, Maltoni G, Bongiorno C, Tucci L, Di Natale V, Moscatiello S, Laffi G, Pession A, Zucchini S, Pagotto U. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study. BMJ Open Diabetes Res Care. 2020;8: e001664.

Article  PubMed  PubMed Central  Google Scholar 

Dovc K, Osredkar SR, Schweiger DS, Battelino T, Bratina N. Nationwide digital/virtual diabetes care of children, adolescents and young adults with type 1 diabetes during a covid-19 pandemic in Slovenia. Slovenian Med J. 2020;89:626–33.

Article  Google Scholar 

Dover A, Ritchie S, McKnight J, Strachan M, Zammitt N, Wake D, Forbes S, Stimson R, Gibb F. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring. Diabet Med. 2021;38: e14374.

Article  CAS  PubMed  Google Scholar 

Fernández E, Cortazar A, Bellido V. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2020;166: 108348.

Article  PubMed  PubMed Central  Google Scholar 

Lawrence N, Natarajan A, Petkar R, Joseph L: Impact of COVID-19 lockdown on glycaemic control in young people with type 1 diabetes: a retrospective review at a large hospital. Diabetes Care for Children & Young People 2020, 10.

Longo M, Caruso P, Petrizzo M, Castaldo F, Sarnataro A, Gicchino M, Bellastella G, Esposito K, Maiorino MI. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy. Diabetes Res Clin Pract. 2020;169: 108440.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marigliano M, Maffeis C. Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy. Acta Diabetol. 2021;58:661–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mesa A, Viñals C, Pueyo I, Roca D, Vidal M, Giménez M, Conget I. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Res Clin Pract. 2020;167: 108354.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moreno-Domínguez Ó. González-Pérez de Villar N, Barquiel B, Hillman-Gadea N, Gaspar-Lafuente R, Arévalo-Gómez M, Herranz L: Factors related to improvement of glycemic control among adults with type 1 diabetes during lockdown due to COVID-19. Diabetes Technol Ther. 2021;23:399–400.

Article  PubMed  Google Scholar 

Pla B, Arranz A, Knott C, Sampedro M, Jiménez S, Hernando I, Marazuela M: Impact of COVID-19 lockdown on glycemic control in adults with type 1 diabetes mellitus. Journal of the Endocrine Society 2020, 4:bvaa149.

Prabhu Navis J, Leelarathna L, Mubita W, Urwin A, Rutter MK, Schofield J, Thabit H. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England. Acta Diabetol. 2021;58:231–7.

Article  CAS  PubMed  Google Scholar 

Predieri B, Leo F, Candia F, Lucaccioni L, Madeo SF, Pugliese M, Vivaccia V, Bruzzi P, Iughetti L. Glycemic control improvement in Italian children and adolescents with type 1 diabetes followed through telemedicine during lockdown due to the COVID-19 pandemic. Front Endocrinol. 2020;11: 595735.

Article  Google Scholar 

Viñals C, Mesa A, Roca D, Vidal M, Pueyo I, Conget I, Giménez M. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump. Acta Diabetol. 2021;58:383–8.

Article  PubMed  Google Scholar 

Brener A, Mazor-Aronovitch K, Rachmiel M, Levek N, Barash G, Pinhas-Hamiel O, Lebenthal Y, Landau Z. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown. Acta Diabetol. 2020;57:1511–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caruso I, Di Molfetta S, Guarini F, Giordano F, Cignarelli A, Natalicchio A, Perrini S, Leonardini A, Giorgino F, Laviola L. Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes. Diabetes Metab Res Rev. 2021;37: e3404.

Article  CAS  PubMed  Google Scholar 

Cotovad-Bellas L, Tejera-Pérez C, Prieto-Tenreiro A, Sánchez-Bao A, Bellido-Guerrero D. The challenge of diabetes home control in COVID-19 times: proof is in the pudding. Diabetes Res Clin Pract. 2020;168: 108379.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ludvigsson J: Effect of COVID‐19 pandemic on treatment of Type 1 diabetes in children. Acta Paediatrica (Oslo, Norway: 1992) 2021, 110:933.

Al Agha AE, Alharbi RS, Almohammadi OA, Yousef SY, Sulimani AE, Alaama RA. Impact of COVID-19 lockdown on glycemic control in children and adolescents. Saudi Med J. 2021;42:44.

Article  PubMed  Google Scholar 

Assaloni R, Pellino VC, Puci MV, Ferraro OE, Lovecchio N, Girelli A, Vandoni M. Coronavirus disease (Covid-19): how does the exercise practice in active people with type 1 diabetes change? A preliminary survey. Diabetes Res Clin Pract. 2020;166: 108297.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barchetta I, Cimini FA, Bertoccini L, Ceccarelli V, Spaccarotella M, Baroni MG, Cavallo MG. Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy. Diabetes Res Clin Pract. 2020;170: 108513.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenbauer J, Neu A, Rothe U, Seufert J, Holl RW. Types of diabetes are not limited to age groups: type 1 diabetes in adults and type 2 diabetes in children and adolescents. J Health Monitoring. 2019;4:29.

Google Scholar 

Ceconi V, Barbi E, Tornese G. Glycaemic control in type 1 diabetes mellitus and COVID-19 lockdown: what comes after a" quarantine"? J Diabetes. 2020;12:946–8.

Article  CAS  PubMed  Google Scholar 

Christoforidis A, Kavoura E, Nemtsa A, Pappa K, Dimitriadou M. Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system. Diabetes Res Clin Pract. 2020;166: 108307.

Article  CAS  PubMed  PubMed Central